Nexalin Technology logo

Nexalin Technology

NXL | NASDAQ
Chart Builder DCF Calculator
$1.56
+$0.08 (+5.41%)
At close: Nov 16, 2026, 4:00 PM ET
$1.54
-$0.02 (-1.28%)
After-hours: Nov 16, 2026, 6:00 PM ET
+5.41%

Rating

Updated: Nov 16, 2026
32.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #722/1021 (Top 71%)

Key Statistics

Market Data

Market Cap $1.93M
1D Range
1.45 1.61
52W Range
1.40 32.70

Valuation (TTM)

PE -0.11
PB 7.33
EV/EBITDA -0.26

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Loading financial charts...

Profile

Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. ...

Sector Healthcare
Employees 8
IPO Date Sep 16, 2022
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$3.43
Miss -17.87%
REV
$78.3K
Beat +4.40%
Next Earnings
Mar 24, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.